Literature DB >> 34742926

Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon.

Gédéon Prince Manouana1, Moustapha Nzamba Maloum2, Rodrigue Bikangui3, Sam O'neilla Oye Bingono2, Georgelin Ondo Nguema2, Josiane Yabo Honkpehedji2, Elie Gide Rossatanga4, Samira Zoa-Assoumou5, Srinivas Reddy Pallerla6, Sivaramakrishna Rachakonda6, Armel Ndong Mintsa7, Jean-Bernard Lekana-Douki8, Joël-Fleury Djoba Siawaya9, Steffen Borrmann10, Peter Gottfried Kremsner10, Bertrand Lell11, Thirumalaisamy P Velavan12, Ayola Akim Adegnika13.   

Abstract

OBJECTIVE: Variants of concern (VOCs) associated with relatively high transmissibility appear to be rapidly spreading in Gabon. Therefore, it is imperative to understand the distribution of several VOCs in the population, which could have implications for transmissibility and vaccine efficacy.
METHODS: Between February and May 2021, SARS-CoV-2 genomes were sequenced using the Oxford nanopore MinION method and the respective genome diversity was elucidated. Phylogenetic analysis was performed and genomes were classified using pangolin lineages.
RESULTS: The results highlighted an increase (46%) in the alpha VOC (B.1.1.7) in the Gabonese population over the study period. In addition, an increase (31%) in the B.1.1.318 lineage, which is associated with high transmission and impaired vaccine efficacy (D614G+E484K+Y144del), was detected.
CONCLUSION: With the second wave ongoing, these findings highlight the need for surveillance of the SARS-CoV-2 genome in the Republic of Gabon and should provide useful guidance to policymakers in selecting an appropriate vaccine for this population.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  B.1.1.318; B.1.1.7; Central Africa; Gabon; MinION; Oxford Nanopore; SARS-CoV-2; Transmission; Variant of concern

Mesh:

Year:  2021        PMID: 34742926      PMCID: PMC8563502          DOI: 10.1016/j.ijid.2021.10.057

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   12.074


Introduction

SARS-CoV-2 variants of concern (VOC) appear to spread more easily. Other emerging variants are also gaining attention, either known as a "variants of interest" (VOI) or "variants under investigation" (VUI), which increase transmission, warranting further studies. Since the onset of the COVID-19 pandemic, the SARS-CoV-2 genomes have accumulated genetic diversity, leading to increased transmission with altered viral properties (Kraemer et al. 2021). Of the several new SARS-CoV-2 variants recently reported, alpha VOC B.1.1.7 (associated with the N501Y mutation) (Rambaut et al. 2020), beta VOC B.1.351 (associated with the E484K mutation) (Tegally et al. 2021), and gamma VOC P.1 (B.1.1.28.1, mutations with likely epidemiological significance E484K, K417T, and N501Y) (Graf et al. 2021), and the delta VOC B.1.617.2 (mutations with likely epidemiological significance P681R, K417N, and L452R) are of great interest. B.1.1.318 has recently been reported as a VOI, carrying D614G, D796H, E484K, P681H, T95I, Y144del, among which D614G has been implicated in increased transmissibility, and E484K with decreased vaccine efficacy. The Republic of Gabon has evidence of a circulating alpha VOC B.1.1.7 (Zoa-Assoumou et al. 2021) and has thus far recorded 25,819 confirmed cases with 165 deaths until 30 August 2021 (WHO 2021). This may be due to factors such as age, demographics, and the constant exposure and burden of co-infections (e.g. with helminths) (Velavan et al. 2021). The current second wave, which has been ongoing since February 2021, has led to increased SARS-Cov2 genomic surveillance. This study aimed to reveal the actual distribution of SARS-CoV-2 variants circulating in the country.

Materials and Methods

The Centre de Recherches Médicales de Lambaréné undertook COVID-19 surveillance between February and May 2021. The study participants were residents living in the Lambaréné region.

NGS sequencing and phylogenetic analysis

Samples with confirmed Ct values ≤30 were subsequently sequenced using the MinION sequencing platform (Oxford Nanopore Technologies, Oxford, UK). Libraries were prepared according to the nCoV-2019 sequencing protocol (RAPID barcoding, 1200 bp amplicon) V.3 (Freed et al. 2021). Viral genome assembly was performed using the ARTIC pipeline (https://github.com/artic-network/fieldbioinformatics). SARS-CoV-2 genomes (n=74) circulating between February and May 2021 were retrieved from the global database for influenza gene sequences (GISAID) for African (n=15) and European (n=14) lineages. Only complete viral genomes were included in the analysis, and different previously represented lineages (n=27) from 29 countries were included. All 74 genomes in the present study were aligned with Wuhan-Hu-1 strain (NC_045512.2) using the Multiple Alignment using Fast Fourier Transform (MAFTT) algorithm (Katoh et al. 2002). The phylogenetic tree was reconstructed with the maximum likelihood method with 1000 bootstrap iteration using the general time-reversible (GTR) model with rate heterogeneity (GTR+G) in the IQ-TREE server (Trifinopoulos et al. 2016). SARS-CoV-2 genomes were classified into lineages using Phylogenetic Assignment of Named Global Outbreak LINeages (pangolin) (O'Toole et al. 2021) and viral clades by Nextclade Beta (https://clades.nextstrain.org/). The final dataset was displayed with FigTree v1.4.4.

Results

The sequenced SARS-COV-2 genomes and their respective genome diversity with distinct viral lineages are summarized in Table 1 , and the sequences were submitted to the GISAID database. Of the 71 SARS-COV-2 genomes, the alpha VOC B.1.1.7 lineage (46%) was predominant, followed by B.1.1.318 (31%), B.1 (7%), S.1, B.1.214.2 and B.1.620 (3%, respectively), and beta VOC B.1.351 (1%), B.1.400, B.1.525, B.1.619 and B.1.1 (1%, respectively). The identified alpha VOCs clustered into two GISAID clades GR (n=7/33) and GRY (n=26/33), whereas others clustered to either of the GISAID clades G, GH and GR. The proportion of B.1.1.318 increased systematically from 11% (3/27) in March, followed by 37% (7/19) in April to 75% (12/16) in May, and the B.1.1.318 genomes were representative of GISAID clades GR. Phylogenetic analysis showed that 71 SARS-CoV-2 genomes from Gabon sequestered into 10 groups, each representing a distinct SARS-CoV-2 lineage (Figure 1 ). The B.1.1.318 lineage was polyphyletic, as the cluster had sequences from Europe and parts of Africa. The B.1.1.7 lineage was paraphyletic, as the majority of the sequences from Gabon were grouped into a distinct sister clade. Among the other sequences, B.1.214.2, B.1, B.1.620, B.1.619 and B.1.525 formed monophyletic groups. Of the rest, two solitary sequences represented by B.1, B.1.351 did not cluster, and the solitary B.1.1 sequence was paraphyletic to B.1.1.318 lineage (Figure 1).
Table 1

Proportion of Gabonese SARS-CoV-2 viral lineages.

PANGO lineageFrequency (%)GISAID ID
B.1.1.7 (N=33)46EPI_ISL_1615655; EPI_ISL_1911957; EPI_ISL_1911965; EPI_ISL_1913030; EPI_ISL_1913034; EPI_ISL_1913035; EPI_ISL_1913050; EPI_ISL_1913052; EPI_ISL_1913055; EPI_ISL_1913058; EPI_ISL_1913060;EPI_ISL_1913070; EPI_ISL_2036078; EPI_ISL_2036091; EPI_ISL_2036130; EPI_ISL_2036198; EPI_ISL_2036199; EPI_ISL_2036201; EPI_ISL_2036261; EPI_ISL_2036271; EPI_ISL_2036273; EPI_ISL_2097218; EPI_ISL_2156769; EPI_ISL_2156770;EPI_ISL_2156795; EPI_ISL_2156809; EPI_ISL_2424137; EPI_ISL_2424138; EPI_ISL_2424139; EPI_ISL_2424159; EPI_ISL_2434975
B.1.1.318 (N=22)31EPI_ISL_1913078; EPI_ISL_2036080; EPI_ISL_2036090; EPI_ISL_2036270; EPI_ISL_2097220- EPI_ISL_2097222; EPI_ISL_2097231; EPI_ISL_2424160- EPI_ISL_2424163; EPI_ISL_2434970; EPI_ISL_2434971; EPI_ISL_2434974; EPI_ISL_2434980; EPI_ISL_2442203; EPI_ISL_2442277; EPI_ISL_2442279; EPI_ISL_2442338; EPI_ISL_2442383; EPI_ISL_2442384
B.1 (N=5)7EPI_ISL_2035987; EPI_ISL_2036089; EPI_ISL_2036200; EPI_ISL_2036274; EPI_ISL_2156806
S.1 (N=2)3EPI_ISL_1913080; EPI_ISL_2097230
B.1.214.2 (N=2)3EPI_ISL_2424157; EPI_ISL_2424158
B.1.620 (N=2)3EPI_ISL_2434979; EPI_ISL_2442363
B.1.400 (N=1)1EPI_ISL_2156807
B.1.525 (N=1)1EPI_ISL_2156768
B.1.619 (N=1)1EPI_ISL_1913075
B.1.1 (N=1)1EPI_ISL_2442276
B.1.351 (N=1)1EPI_ISL_2424136
Figure 1

Maximum likelihood phylogenetic tree of currently available SARS-CoV-2 genomes from the Republic of Gabon (nodes and branches highlighted in cyan; names in blue). Numbers above branches represent percentages of bootstrap values (1000 replicates). All the full-length genomes retrieved from the GISAID (global database for influenza gene sequences) labelled as country of origin, GISAID ID., and PANGOLIN lineage. Branch lengths are drawn according to the number of nucleotide substitutions per site.

Proportion of Gabonese SARS-CoV-2 viral lineages. Maximum likelihood phylogenetic tree of currently available SARS-CoV-2 genomes from the Republic of Gabon (nodes and branches highlighted in cyan; names in blue). Numbers above branches represent percentages of bootstrap values (1000 replicates). All the full-length genomes retrieved from the GISAID (global database for influenza gene sequences) labelled as country of origin, GISAID ID., and PANGOLIN lineage. Branch lengths are drawn according to the number of nucleotide substitutions per site.

Discussion

The observation of an increase in incidence of B.1.1.318 from 11% to 75% between March and May 2021 is of interest. Variant B.1.1.318 was discovered in January 2021. Phylogenetic analysis (Figure 1) revealed that all 33 isolates in the B.1.1.7 clade formed a distinct cluster. On the other hand, 22 isolates fell into two relatively cohesive phylogenetic clusters of B.1.1.318 genomes, with the first ancestral to the second, suggesting two distinct genetic divergences, the first due to early introduction by imported cases and subsequently evolving within Africa. Similarly, the SARS-CoV-2 genomes from clades B.1.214.2, B.1.351, B.1.525, B.1.19 and B.1.620 suggest that they could be recent introductions to the Gabonese and are therefore less abundant. Taken together, this study highlights circulating new variants of potential epidemiological importance.

Conflicts of interest

The authors declare no conflict of interest in the submitted work.
  9 in total

1.  MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform.

Authors:  Kazutaka Katoh; Kazuharu Misawa; Kei-ichi Kuma; Takashi Miyata
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

2.  W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis.

Authors:  Jana Trifinopoulos; Lam-Tung Nguyen; Arndt von Haeseler; Bui Quang Minh
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

3.  Detection of a SARS-CoV-2 variant of concern in South Africa.

Authors:  Houriiyah Tegally; Eduan Wilkinson; Marta Giovanetti; Arash Iranzadeh; Vagner Fonseca; Jennifer Giandhari; Deelan Doolabh; Sureshnee Pillay; Emmanuel James San; Nokukhanya Msomi; Koleka Mlisana; Anne von Gottberg; Sibongile Walaza; Mushal Allam; Arshad Ismail; Thabo Mohale; Allison J Glass; Susan Engelbrecht; Gert Van Zyl; Wolfgang Preiser; Francesco Petruccione; Alex Sigal; Diana Hardie; Gert Marais; Nei-Yuan Hsiao; Stephen Korsman; Mary-Ann Davies; Lynn Tyers; Innocent Mudau; Denis York; Caroline Maslo; Dominique Goedhals; Shareef Abrahams; Oluwakemi Laguda-Akingba; Arghavan Alisoltani-Dehkordi; Adam Godzik; Constantinos Kurt Wibmer; Bryan Trevor Sewell; José Lourenço; Luiz Carlos Junior Alcantara; Sergei L Kosakovsky Pond; Steven Weaver; Darren Martin; Richard J Lessells; Jinal N Bhiman; Carolyn Williamson; Tulio de Oliveira
Journal:  Nature       Date:  2021-03-09       Impact factor: 49.962

4.  COVID-19 and syndemic challenges in 'Battling the Big Three': HIV, TB and malaria.

Authors:  Thirumalaisamy P Velavan; Christian G Meyer; Meral Esen; Peter G Kremsner; Francine Ntoumi
Journal:  Int J Infect Dis       Date:  2021-03-26       Impact factor: 3.623

5.  Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence.

Authors:  Moritz U G Kraemer; Verity Hill; Christopher Ruis; Simon Dellicour; Sumali Bajaj; John T McCrone; Guy Baele; Kris V Parag; Anya Lindström Battle; Bernardo Gutierrez; Ben Jackson; Rachel Colquhoun; Áine O'Toole; Brennan Klein; Alessandro Vespignani; Erik Volz; Nuno R Faria; David M Aanensen; Nicholas J Loman; Louis du Plessis; Simon Cauchemez; Andrew Rambaut; Samuel V Scarpino; Oliver G Pybus
Journal:  Science       Date:  2021-07-22       Impact factor: 63.714

6.  Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern.

Authors:  Tiago Gräf; Gonzalo Bello; Taina Moreira Martins Venas; Elisa Cavalcante Pereira; Anna Carolina Dias Paixão; Luciana Reis Appolinario; Renata Serrano Lopes; Ana Carolina Da Fonseca Mendonça; Alice Sampaio Barreto da Rocha; Fernando Couto Motta; Tatiana Schäffer Gregianini; Richard Steiner Salvato; Sandra Bianchini Fernandes; Darcita Buerger Rovaris; Andrea Cony Cavalcanti; Anderson Brandão Leite; Irina Riediger; Maria do Carmo Debur; André Felipe Leal Bernardes; Rodrigo Ribeiro-Rodrigues; Beatriz Grinsztejn; Valdinete Alves do Nascimento; Victor Costa de Souza; Luciana Gonçalves; Cristiano Fernandes da Costa; Tirza Mattos; Filipe Zimmer Dezordi; Gabriel Luz Wallau; Felipe Gomes Naveca; Edson Delatorre; Marilda Mendonça Siqueira; Paola Cristina Resende
Journal:  Virus Evol       Date:  2021-12-15

7.  SARS-CoV-2 emerging variants in Africa: view from Gabon.

Authors:  Samira Zoa-Assoumou; Bénédicte Ndeboko; Gédéon Prince Manouana; Rotimi Myrabelle Avome Houechenou; Rodrigue Bikangui; Amandine Mveang-Nzoghe; Georgelin Nguema Ondo; Elvyre Mbongo-Kama; Bertrand Lell; Haruka Abe; Yuri Ushijima; Anne-Marie Antchouey; Jiro Yasuda; Ayola Akim Adegnika; Joel Fleury Djoba Siawaya
Journal:  Lancet Microbe       Date:  2021-06-08

8.  Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding.

Authors:  Nikki E Freed; Markéta Vlková; Muhammad B Faisal; Olin K Silander
Journal:  Biol Methods Protoc       Date:  2020-07-18
  9 in total
  5 in total

1.  Screening and Whole Genome Sequencing of SARS-CoV-2 Circulating During the First Three Waves of the COVID-19 Pandemic in Libreville and the Haut-Ogooué Province in Gabon.

Authors:  Sonia Etenna Lekana-Douki; Nadine N'dilimabaka; Anthony Levasseur; Philippe Colson; Julia Cyrielle Andeko; Ornella Zong Minko; Octavie Banga Mve-Ella; Pierre-Edouard Fournier; Christian Devaux; Bertrand Mve Ondo; Falone Larissa Akombi; Laurianne Yacka Mouele Bolo; Audrey Michel Ngonga Dikongo; Abdoulaye Diané; Arsène Mabika Mabika; Jenny Francine Mathouet; Cresh Dzembo; Nick Chenis Atiga; Anicet Mouity Matoumba; Nal Kennedy Ndjangangoye; Ludivine Bréchard; Marielle Bedotto-Buffet; Joa Braithe Mangombi Pambou; Marisca Kandet Yattara; Elvire Anita Mbongo Nkama; Armel Mintsa Ndong; Ayola Akim Adegnika; Didier Raoult; Florence Fenollar; Jean-Bernard Lekana-Douki
Journal:  Front Med (Lausanne)       Date:  2022-05-17

2.  SARS-CoV-2 viral dynamics of the first 1000 sequences from Vietnam and neighbouring ASEAN countries.

Authors:  Nghiem Xuan Hoan; Srinivas Reddy Pallerla; Pham Xuan Huy; Hannah Krämer; Truong Nhat My; Tran Thanh Tung; Phan Quoc Hoan; Nguyen Linh Toan; Le Huu Song; Thirumalaisamy P Velavan
Journal:  IJID Reg       Date:  2022-01-20

3.  Unusual N Gene Dropout and Ct Value Shift in Commercial Multiplex PCR Assays Caused by Mutated SARS-CoV-2 Strain.

Authors:  Petros Bozidis; Eleni T Tsaousi; Charilaos Kostoulas; Prodromos Sakaloglou; Athanasia Gouni; Despoina Koumpouli; Hercules Sakkas; Ioannis Georgiou; Konstantina Gartzonika
Journal:  Diagnostics (Basel)       Date:  2022-04-13

Review 4.  Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19.

Authors:  Hong Zhou; Wei-Jian Ni; Wei Huang; Zhen Wang; Ming Cai; Yan-Cai Sun
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

Review 5.  COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2.

Authors:  Debashis Dutta; Sarah Naiyer; Sabanaz Mansuri; Neeraj Soni; Vandana Singh; Khalid Hussain Bhat; Nishant Singh; Gunjan Arora; M Shahid Mansuri
Journal:  Diagnostics (Basel)       Date:  2022-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.